International Business Machines Corporation

General Electric Company

Novatek Microelectronics Corp.

Shaanxi University of Science and Technology

Wex Medical Limited

Other

Dell Products Inc.

Guangdong Raynovent Biotech Co., Ltd.

Siemens Aktiengesellschaft

Ecolab USA Inc.

Philips Lighting Holding B.v.

Xi'an Jiaotong University

Bl Technologies, Inc.

Amlogic (shanghai) Co., Ltd.

Shanghai Techwell Biopharmaceutical Co., Ltd.

Xiao Xun Zhang

Zhong Su

Jing Min Xu

Fan Jing Meng

Lin Y Yang

Hui Zhu

Chuan Lin

Qijia Fu

Rui Ma

Wenqing Peng

Keke Cai

Zhili Guo

Xian Wu

Jing Luo

Shizhong Wang

Jianfeng Huang

Liyun Cao

Liangliang Feng

Weiyang Lin

Jinxin Yu

Xiaoyan Huang

Jian Li

Shuhui Chen

Ying Li

Lawrence Bernard Kool

Wei Zhang

Haiying He

Honglei Guo

Jun Sun

Zhigan Jiang

Yanfei Gu

Zhigang Deng

Hong Lei Guo

Zhaoping Wu

Peng Chen

JianHua Liang

Xin Hu

Qiqiang Han

Haiyan Liu

Qianqian Liu

Youhao Yang

Ping Zhu

Li Ni Zhang

Xing Liu

Yan Wang

Larry Neil Lewis

Yuan Wang

Shi Lei Zhang

Jian He

Bo Wang

Jing Wang

Daniel George Norton

Yan Chen

Xiaoming Ji

Naga A Ayachitula

Bo Hu

Jie Ping Wu

John Brian McDermott

Jian Huang

Chaofeng Long

Xiaoxin Chen

Shenghua Bao

Yulin Zhao

Zhiqiang Liu

Jie Wang

Yan Xiong

Beverly Lubit

Nimeshkumar Kantilal Patel

Shidong Liu

Zhijun Tang

Zhen Gong

Liang Fang

Hongbin Li

Zhaoli Zhang

Yu Dong

Xiaoan Xie

Tong Zhu

Hitesh Ghanshyam Bagaria

Jian-Hua Liang

Jun W Zhang

Ling Zhu

Zhi Li Guo

Xiusheng Wang

Ben Fei

Ying Dan Zhu

Yun Peng

Zhi Hua Pan

Yuanjia Du

Xiaotong Liu

Dejia Wang

Huijuan Shi

Jia Wu

Guoliang Wang

Yang He

Pengfei Chen

Susan Corah

Yue Wang

Xiaoying Bao

Jian Xu

Provided is a three-phase system VO/VN/MoC nanoelectrode material, and a preparation method and application thereof. The nanoelectrode material comprises VOparticles, VN particles, and MoC particles. The VOparticles, VN particles, and MoC particles are interlaced in lattice stripes and are uniformly distributed. The mass ratio of the VO, VN and MoC is (1 to 4):(10 to 40):(4 to 16). The above-mentioned three kinds of nanoparticles are intertwined to form more incoherent interface area. The increase in the area of the incoherent interface area will cause more defects, so that more active sites are provided, and the hydrogen production performance is improved.

Three-phase system vanadium trioxide/vanadium nitride/molybdenum carbide nanoelectrode material, and preparation method and application thereof

The present invention relates to a ventilating and blanking device for a coal storage Eurosilo. The ventilating and blanking device includes a top blanking pipe, an axial flow fan and a baffle door, the top blanking pipe including a first pipeline and a second pipeline, an air supply pipe is connected to a side wall of the second pipeline, and the baffle door is connected to a driving mechanism; during blanking, the driving mechanism drives the baffle door so as to make the baffle door close the air supply pipe and the axial flow fan is shut off; and during ventilation, the driving mechanism drives the baffle door so as to make the baffle door close the first pipeline, and the axial flow fan is turned on. Compared with the prior art, the present invention has the advantages of ventilation efficiency, good ventilation effect, etc.

Ventilating and blanking device for coal storage Eurosilo

The use of a genetic method to down-regulate RBO/EFR3/EFR3A/EFR3B proteins, TTC7 protein or PI4KIII&#x3b1; enzyme protein which interacts with RBO/EFR3/EFR3A/EFR3B proteins and TTC7 protein, or the use of a drug to inhibit PI4KIII&#x3b1; protein kinase activity reduces the accumulation of A&#x3b2;within neurons and age-dependent synaptic transmission failure and other obstacles in a fruit fly AD model, and obtains an effect of improving the learning and memory abilities of AD model mice. Provided is a method for using an RBO/EFR3/EFR3A/EFR3B inhibitor, a TTC7 inhibitor and a PI4KIII&#x3b1; inhibitor to treat Alzheimer's disease. Also provided is a method for screening a drug treating Alzheimer's disease by whether A&#x3b2; secretion by nerve cells is promoted or not.

Application of PI4KIIIA protein and related membrane protein complex in treating alzheimer's disease

The present invention relates to a core-shell FeP@C&#x2014;FeC electrocatalyst and a preparation method and application thereof. The core-shell FeP@C&#x2014;FeC electrocatalyst comprises a carbon nanotube as a matrix which is formed by a carbon layer with FeCnano-dots distributed therein, and FeP@C embedded in the carbon nanotube. The FeP@C has a core-shell structure and is formed by coating FeP with carbon.

Core-shell FE2P@c-FE3C electrocatalyst and preparation method and application thereof

The present invention relates to a support device used in weighing coal of a raw coal bunker in a thermal power plant and a weighable raw coal bunker. The support device includes a base, a positioning sleeve, an upper support and a weighing sensor, a sensor groove being provided in the middle of the base, the weighing sensor being arranged in the sensor groove, the positioning sleeve being arranged on the base in a covering mode, a positioning hole being provided in the middle of the positioning sleeve, the upper support being movably inserted in the positioning hole, and a bottom surface of the upper support penetrating the positioning hole to abut against a top surface of the weighing sensor. The raw coal bunker uses the support device. Compared with the prior art, the present invention effectively meets the weighing requirement of the raw coal bunker.

Support device used in weighing coal of raw coal bunker in thermal power plant and weighable raw coal bunker

The invention relates to a V-NiP/g-CNphotocatalyst, a preparation method, and application thereof. The V-NiP/g-CNphotocatalyst is a composite material of V-NiP and g-CN, wherein V-NiP has the spherical structure formed by nanosheets; the mass ratio of the V-NiP and g-CNis (0.01 to 0.2):1.

V-NiP/g-CNphotocatalyst and its preparation method and application thereof

The present invention relates to an anti-skid speed measurement and material flow detection device for a belt conveyor, include a base symmetrically arranged on the intermediate frame of the belt conveyor and arranged between two groups of slotted roller supports, sliding supports arranged on the base, a speed measurement roller and a sensor arranged on the two groups of sliding supports, and a control system connected with the sensor, a speed measurement disk is sleeved on an end face of one end of a barrel of the speed measurement roller, a circular hole is formed on the circumference of the speed measurement disk, the circular hole is arranged corresponding to the position of the senso. Compared with the prior art, the present invention has the advantages of dramatically reduced production cost and maintenance cost, simple structure and high reliability.

Anti-skid speed measurement and material flow detection device for belt conveyor

Described herein are systems and methods for evaluating and mitigating the wax risks of a given hydrocarbon composition such as crude oil. The disclosed systems and methods enable rapid and ready prediction of wax risks using algorithms based on a small sample of the hydrocarbon composition. The wax risks are predicted using predictive models developed from machine learning. The disclosed systems and methods include mitigation strategies for wax risks that can include chemical additives, operation changes, and/or hydrocarbon blend.

Wax risk assessment and mitigation using advanced data analytics and pipe flow modeling

The present disclosure provides, in part, a priming and boosting vector-based platform to develop vaccines against pathogens that is tailored to elicit a broad T cell response targeting conserved viral epitopes. The universal vaccines are prepared against an immunogen of an infectious pathogenic organism selected from a virus, a bacteria, a fungus or a protozoan comprising at least one ribonucleic acid (RNA) polynucleotide comprising an open reading frame encoding at least one polypeptide antigen or an immunogenic fragment thereof, wherein the polypeptide antigen, or the immunogenic fragment thereof, comprises a conserved internal protein that is enriched in CD8+ T cell recognition antigens. The effectiveness of the priming and boosting platform is tested in a humanized mouse model comprising a fully functional human immune system.

Universal vaccines against immunogens of pathogenic organisms that provide organism-specific and cross-group protection

The present invention relates to an amorphous pyrrolidine derivative as a PPAR agonist and a preparation method thereof.

Amorphous pyrrolidine derivative as PPAR agonist and preparation method thereof

Systems and methods for ticket classification and response include labeling tickets with a ticket classifier that assigns a ticket label and an associated confidence score to each ticket. Tickets are clustered according to semantic similarity to form ticket clusters. A template associated with each ticket cluster is determined. Templates and the respective ticket clusters are clustered according to semantic similarity to form one or more ticket super-clusters. Tickets that have below-threshold confidence scores are labeled according to the one or more ticket super-clusters. The tickets are automatically responded to.

Hybrid learning-based ticket classification and response

Embodiments facilitating performance anomaly detection are described. A computer-implemented method comprises: detecting, by a device operatively coupled to one or more processing units, based on monitoring data of a plurality of performance metrics of a monitored device, at least one trend within the monitoring data of the respective performance metrics; removing, by the device, the at least one trend from the monitoring data of the respective performance metrics to generate modified data of the respective performance metrics; and detecting, by the device, a performance anomaly based on the modified data of the respective performance metrics and a behavior clustering model comprising at least one steady state.

Performance anomaly detection

Disclosed is the use of genetic means or a related inhibitor to inhibit and down-regulate the amount of PI4KIII&#x3b1; protein, RBO/EFR3/EFR3A/EFR3B membrane proteins, TTC7 protein and membrane protein complexes formed by said proteins, or related enzyme activity to promote A&#x3b2; secretion by neuronal cells, reduce A&#x3b2; accumulation within neurons, and thereby reduce AD model fruit fly and mouse nerve dysfunction.

Method for screening drug and therapeutic targets used for treating Alzheimer's disease

The disclosure provides an image adjustment device configured to be different modes according to whether the adopted display is a light emitting diode display or a liquid crystal display, and including a duty cycle calculator, an intensity calculator and a compensator. In a first mode, the duty cycle calculator determines a respective type of each segment according to brightness information of each segment, and sets a duty cycle value according to the type of the segment. In a second mode, the duty cycle calculator calculates the duty cycle value according to the brightness information of each segment. The intensity calculator calculates the pixel intensity of the segment based on the duty cycle value and a light diffusion coefficient set. The compensator generates a pixel gain value according to the intensity value of each pixel of the segment, and adjusts the pixel value according to the pixel gain value.

Image adjustment device for a display comprising a duty cycle calculator configured to receive an input image and an intensity calculator configured to calculate a pixel intensity and image adjustment method

A method, system, and computer program product, include extracting information related to one or more processes of one or more applications running on a virtual machine from a memory of the virtual machine, building at least one first application signature based on the extracted information, and identifying the one or more applications running on the virtual machine by matching the at least one first application signature with one or more second application signatures previously stored.

Method, system, and computer program product for application identification in a cloud platform

Growing community of inventors

Beijing, China

Xiao Xun Zhang